Memantine in moderately-severe-to-severe Alzheimer's disease: a postmarketing surveillance study

MLA

Clerici F, et al. “Memantine in Moderately-Severe-to-Severe Alzheimer’s Disease: A Postmarketing Surveillance Study.” Drugsaging, vol. 26, no. 4, May 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....89afc8118980d9c526dc29773cf91df3&authtype=sso&custid=ns315887.

APA

Clerici F, Vanacore N, Elia A, Spila Alegiani S, Pomati S, D. C. R., Raschetti R, Mariani C, Memantine Lombardy Study Group, Altavilla, R., Appollonio, I., Isella, V., Avanzi, S., Bargnani, C., Bascelli, C., Bellelli, G., Guerini, F., Belotti, G., Bottini, G., Gerini, M., … Alberici, A. (2009). Memantine in moderately-severe-to-severe Alzheimer’s disease: a postmarketing surveillance study. Drugsaging, 26(4).

Chicago

Clerici F, Vanacore N, Elia A, Spila Alegiani S, Da Cas R Pomati S, Raschetti R, Mariani C, et al. 2009. “Memantine in Moderately-Severe-to-Severe Alzheimer’s Disease: A Postmarketing Surveillance Study.” Drugsaging 26 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....89afc8118980d9c526dc29773cf91df3&authtype=sso&custid=ns315887.